1. Bennett, A.M. and Norris, K.P., Evaluation of Hazards From Exposure to Microorganisms and Their Products., State of The Art Report No. 2, Industrial Biosafety Project, Warren Spring Laboratory, Stevenage, 1988.
2. Topping, M.D., Scarisbrick, D.A., Luczynska, C.M., Clarke, E.C. and Seaton A., Clinical and immunological reaction to Aspergillus niger among workers at a biotechnological plant. British J. Industrial Medicine., 1985, 42, 312–318.
3. Harris-Smith, R. and Evans, C.G.T., Bioengineering and protection during hazardous microbiological processes. Biotechnology and Bioengineering Symposium., 1974, 4, 837–855.
4. Flindt, M.H.L., Pulmonary disease due to inhalation of derivatives of Bacillus subtilis containing proteolytic enzymes. Lancet., 1969(i), 1177–1180.
5. Ekenvall, L., Dolling, B., Gothe, C.J., Ebbinghaus, L., Von Stedingk,L-V and Wasserman,J.M., Single cell protein as an industrial hazard. British J. Industrial Medicine., 1983, 40, 212–215.